143 related articles for article (PubMed ID: 15147218)
21. Structure of anthrax lethal toxin prepore complex suggests a pathway for efficient cell entry.
Fabre L; Santelli E; Mountassif D; Donoghue A; Biswas A; Blunck R; Hanein D; Volkmann N; Liddington R; Rouiller I
J Gen Physiol; 2016 Oct; 148(4):313-24. PubMed ID: 27670897
[TBL] [Abstract][Full Text] [Related]
22. Membrane insertion of anthrax protective antigen and cytoplasmic delivery of lethal factor occur at different stages of the endocytic pathway.
Abrami L; Lindsay M; Parton RG; Leppla SH; van der Goot FG
J Cell Biol; 2004 Aug; 166(5):645-51. PubMed ID: 15337774
[TBL] [Abstract][Full Text] [Related]
23. Protective antigen-binding domain of anthrax lethal factor mediates translocation of a heterologous protein fused to its amino- or carboxy-terminus.
Milne JC; Blanke SR; Hanna PC; Collier RJ
Mol Microbiol; 1995 Feb; 15(4):661-6. PubMed ID: 7783638
[TBL] [Abstract][Full Text] [Related]
24. Effects of dynamin inactivation on pathways of anthrax toxin uptake.
Boll W; Ehrlich M; Collier RJ; Kirchhausen T
Eur J Cell Biol; 2004 Jul; 83(6):281-8. PubMed ID: 15511085
[TBL] [Abstract][Full Text] [Related]
25. Effect of pH on stability of anthrax lethal factor: correlation between denaturation and activity.
Gupta P; Singh S; Tiwari A; Bhat R; Bhatnagar R
Biochem Biophys Res Commun; 2001 Jun; 284(3):568-73. PubMed ID: 11396937
[TBL] [Abstract][Full Text] [Related]
26. Stoichiometry of anthrax toxin complexes.
Mogridge J; Cunningham K; Collier RJ
Biochemistry; 2002 Jan; 41(3):1079-82. PubMed ID: 11790132
[TBL] [Abstract][Full Text] [Related]
27. Dominant-negative mutants of a toxin subunit: an approach to therapy of anthrax.
Sellman BR; Mourez M; Collier RJ
Science; 2001 Apr; 292(5517):695-7. PubMed ID: 11326092
[TBL] [Abstract][Full Text] [Related]
28. Anthrax protective antigen: prepore-to-pore conversion.
Miller CJ; Elliott JL; Collier RJ
Biochemistry; 1999 Aug; 38(32):10432-41. PubMed ID: 10441138
[TBL] [Abstract][Full Text] [Related]
29. Catalytically inactive anthrax toxin(s) are potential prophylactic agents.
Gupta M; Alam S; Bhatnagar R
Vaccine; 2007 Dec; 25(50):8410-9. PubMed ID: 17980467
[TBL] [Abstract][Full Text] [Related]
30. Membrane type-1 matrix metalloproteinase (MT1-MMP) protects malignant cells from tumoricidal activity of re-engineered anthrax lethal toxin.
Rozanov DV; Golubkov VS; Strongin AY
Int J Biochem Cell Biol; 2005 Jan; 37(1):142-54. PubMed ID: 15381157
[TBL] [Abstract][Full Text] [Related]
31. Structure and function of anthrax toxin.
Lacy DB; Collier RJ
Curr Top Microbiol Immunol; 2002; 271():61-85. PubMed ID: 12224524
[TBL] [Abstract][Full Text] [Related]
32. [Toxin-neutralizing monoclonal antibodies to the different domains of anthrax protective antigen].
Xu JJ; Zhang J; Liu SL; Lv TJ; Chen W; Li GL; Ge M; Guo Q
Wei Sheng Wu Xue Bao; 2005 Dec; 45(6):947-51. PubMed ID: 16496709
[TBL] [Abstract][Full Text] [Related]
33. Interactions of anthrax lethal factor with protective antigen defined by site-directed spin labeling.
Jennings-Antipov LD; Song L; Collier RJ
Proc Natl Acad Sci U S A; 2011 Feb; 108(5):1868-73. PubMed ID: 21262847
[TBL] [Abstract][Full Text] [Related]
34. The protective antigen component of anthrax toxin forms functional octameric complexes.
Kintzer AF; Thoren KL; Sterling HJ; Dong KC; Feld GK; Tang II; Zhang TT; Williams ER; Berger JM; Krantz BA
J Mol Biol; 2009 Sep; 392(3):614-29. PubMed ID: 19627991
[TBL] [Abstract][Full Text] [Related]
35. Mapping the anthrax protective antigen binding site on the lethal and edema factors.
Lacy DB; Mourez M; Fouassier A; Collier RJ
J Biol Chem; 2002 Jan; 277(4):3006-10. PubMed ID: 11714723
[TBL] [Abstract][Full Text] [Related]
36. Disulfide bonds in the ectodomain of anthrax toxin receptor 2 are required for the receptor-bound protective-antigen pore to function.
Sun J; Collier RJ
PLoS One; 2010 May; 5(5):e10553. PubMed ID: 20479891
[TBL] [Abstract][Full Text] [Related]
37. Oligomerization of anthrax toxin protective antigen and binding of lethal factor during endocytic uptake into mammalian cells.
Singh Y; Klimpel KR; Goel S; Swain PK; Leppla SH
Infect Immun; 1999 Apr; 67(4):1853-9. PubMed ID: 10085027
[TBL] [Abstract][Full Text] [Related]
38. Role of CypA and Hsp90 in membrane translocation mediated by anthrax protective antigen.
Dmochewitz L; Lillich M; Kaiser E; Jennings LD; Lang AE; Buchner J; Fischer G; Aktories K; Collier RJ; Barth H
Cell Microbiol; 2011 Mar; 13(3):359-73. PubMed ID: 20946244
[TBL] [Abstract][Full Text] [Related]
39. Anthrax edema factor, voltage-dependent binding to the protective antigen ion channel and comparison to LF binding.
Neumeyer T; Tonello F; Dal Molin F; Schiffler B; Benz R
J Biol Chem; 2006 Oct; 281(43):32335-43. PubMed ID: 16954207
[TBL] [Abstract][Full Text] [Related]
40. Protein translocation through the anthrax toxin transmembrane pore is driven by a proton gradient.
Krantz BA; Finkelstein A; Collier RJ
J Mol Biol; 2006 Feb; 355(5):968-79. PubMed ID: 16343527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
